Rici Healthcare Holdings (SEHK:1526) Earnings Slowdown Challenges Bullish Growth Narratives

Rici Healthcare Holdings (SEHK:1526) has reported its FY 2025 first half with revenue of C¥1.1b and net income of C¥55.9m, translating to basic EPS of C¥0.04, while trailing twelve month EPS sits at C¥0.19 on revenue of about C¥2.8b and net income of C¥307.1m. Over recent halves, revenue has moved from C¥1.2b in 1H FY 2024 to C¥1.7b in 2H FY 2024 before settling at C¥1.1b in 1H FY 2025. Over the same periods, basic EPS shifted from C¥0.05 to C¥0.13 and then C¥0.04. With net profit margins running at 11% over the past year and a multi year record of earnings growth, this set of results puts profitability firmly in focus for investors.

See our full analysis for Rici Healthcare Holdings.

With the headline numbers on the table, the next step is to see how this earnings profile lines up with the main stories investors follow about Rici Healthcare Holdings and where those narratives might be challenged by the latest figures.

Curious how numbers become stories that shape markets? Explore Community Narratives

11% margin pairs with slower 3.3% earnings growth

• Over the last 12 months, net profit margin was 11% and earnings grew 3.3%, compared with a five year earnings growth rate of 12.5% per year.
• What stands out for a bullish view is that the business kept an 11% margin while the latest 3.3% earnings growth sits below the 12.5% five year pace, which means:
  • Bulls pointing to a solid five year earnings record can point directly to that 12.5% annual growth, but the 3.3% figure shows the recent step up has been more modest.
  • At the same time, the move from a 10.2% margin to 11% gives bulls a profitability data point that sits alongside the slower growth and keeps the long run story grounded in actual cash generation.

Bulls argue that the steady 11% margin and 12.5% five year earnings growth still matter even as the latest 3.3% growth rate cools the pace, and they set out that full case in the 🐂 Rici Healthcare Holdings Bull Case

Half year swings in net income across FY 2024 and FY 2025

• Looking at the last three halves, net income moved from C¥85.0m in 1H FY 2024 to C¥212.3m in 2H FY 2024, then C¥55.9m in 1H FY 2025 on revenue of C¥1,231.2m, C¥1,693.3m and C¥1,144.8m respectively.
• Critics taking a bearish angle often worry about smaller healthcare operators handling swings in profit, and these halves give them numbers to point to while also adding nuance:
  • Bears can highlight the change from C¥212.3m net income in 2H FY 2024 to C¥55.9m in 1H FY 2025 as a clear step down over just one half year.
  • On the other hand, the fact that 1H FY 2024 net income of C¥85.0m and 1H FY 2025 net income of C¥55.9m both sit within a profitable range challenges the idea that profitability is binary or consistently under pressure.

Skeptics point to those profit swings as a key concern, and the full cautious case is set out in the 🐻 Rici Healthcare Holdings Bear Case

P/E of 4x versus DCF fair value of HK$10.06

• The stock trades on a trailing P/E of 4x, compared with 24.9x for peers and 10.9x for the Hong Kong healthcare industry, and the supplied DCF fair value of HK$10.06 sits well above the current HK$0.87 share price.
• Supporters of a bullish stance see this valuation gap as central to their thesis and the latest fundamentals give them specific hooks:
  • The 4x P/E is materially below both the 24.9x peer average and 10.9x industry level, so anyone arguing the shares are already fully reflecting recent 3.3% earnings growth has to square that with these relative multiples.
  • When that is combined with a DCF fair value of HK$10.06 against a HK$0.87 market price, the numbers present a very large discount that bullish investors weigh alongside the five year 12.5% earnings growth history.

Next Steps

Don't just look at this quarter; the real story is in the long-term trend. We've done an in-depth analysis on Rici Healthcare Holdings's growth and its valuation to see if today's price is a bargain. Add the company to your watchlist or portfolio now so you don't miss the next big move.

If this mix of bullish and cautious signals seems finely balanced, review the numbers yourself promptly and form your own perspective with the 2 key rewards

See What Else Is Out There

Rici Healthcare Holdings shows slower 3.3% earnings growth than its 12.5% five year pace and half year swings in profit that can unsettle investors.

If those earnings swings and cooling growth make you uneasy, compare this setup with companies in the 284 resilient stocks with low risk scores to quickly focus on more stable profiles.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com